Rebranding a biotech to drive enterprise value

Impact

• Unified organization around a clear vision following major strategic pivot

• Helped position the company ahead of $6.5B acquisition by Johnson & Johnson

• Senior leadership cited brand as adding significant value to the transaction 

Role: Led overall engagement and guided the work from strategy through creative development, digital rollout, and launch; co-developed brand platform.

Momenta was a biotech that had just radically transformed its business — exiting the generics market and pivoting toward novel therapies for rare, immune-mediated diseases. The company needed a brand that reflected this new direction and signaled its future to investors, partners, and employees.